Sr. Director, Market Access Analytics
- Employer
- CSL
- Location
- King of Prussia, PA
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Marketing, Market Access
- Required Education
- Associate Degree
- Position Type
- Full time
By clicking apply, your email address will be shared with the employer.
Job Details
The Senior Director, Market Access Analytics as a part of US Insights & Analytics team, will establish and lead CSL Behring's US Payer Analytics capability, building the strategic and analytical foundation required to optimize patient access across the portfolio.
This leader, working closely with Strategic Market Access, Payer Channel Marketing and Market Access Accounts functions, will transform complex payer, claims, and market access data into actionable business insights that influence strategy, improve patient access, and maximize commercial performance. The role requires deep expertise in commercial and government coverage, specialty pharmacy and specialty distributor ecosystems, integrated delivery networks, and the evolving integrated payer landscape within rare and specialty diseases.
This individual will serve as the analytical thought partner to cross-functional partners as well as Senior Leadership.
Reporting Relationships
Position reports into:
Executive Director, US Insights & Analytics
Positions reporting into this position:
Associate Director, Market Access Analytics
2X Sr Manager, Market Access Analytics
Main Responsibilities and Accountabilities
Establish the long-term vision, roadmap, and operating model for US Payer Analytics
Serve as a key member of the US I&A leadership team, ensuring market access insights are integrated with broader commercial insights and priorities.
Develop scalable analytic capabilities, reporting frameworks, dashboards, and data infrastructure supporting payer decision making
Build foundational measurement and KPI frameworks for market access performance
Partner with Data & Analytics teams to improve availability and quality of payer data assets
Develop comprehensive analytics supporting market access strategy and provide actionable recommendations regarding opportunities and emerging access risks including: National and regional coverage assessment, Formulary positioning, Coverage evolution and trends
Move beyond traditional national reporting by developing detailed analytics at the payer account level. (e.g. Health plan performance, PBM performance, IDN performance, Regional payer performance, etc.)
Develop a comprehensive reimbursement analytics capability including: PA approval rates, Denial reasons, Appeals submitted, Appeal success rates, Overturn rates, etc.
Responsibility for oversight and effective management of all team members to include but not limited to the following: Annual objective setting, Mid-year and end of year review, Coaching and counseling as appropriate, Employee development
Stay current with industry benchmarks and best practices to ensure insights and strategies remain competitive and innovative
Position Qualifications and Experience Requirements
Education:
Bachelor's degree required; Master's degree (MBA, MS) preferred
Experience:
15+ years of experience in pharmaceutical, biotechnology, specialty pharmacy, payer, or healthcare analytics
Experience within rare disease, specialty biologics, or specialty pharmaceuticals
Demonstrated success building new analytics capabilities and teams
Deep understanding of the US payer landscape, including:
Commercial health plans
National and regional PBMs ,IDNs, GPOs, SPs, HCOs
Strong understanding of reimbursement pathways across both medical and pharmacy benefits
Experience with market access data (e.g., MMIT, Fingertip Formulary, IQVIA, Komodo, claims databases) and payer policy analytics
Proven ability to influence senior executives through data-driven storytelling and strategic recommendations.
Excellent negotiation, communication, and relationship-building abilities
Strong Change and Leadership skills
Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable.
#LI-hybrid
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Company
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Areas of Expertise
We focus and demonstrate global leadership in three distinct areas—rare and serious diseases; influenza vaccines; and iron deficiency and nephrology.
Rare & Serious Diseases
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Vaccines
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries.
Iron Deficiency & Nephrology
With our iron deficiency and iron deficiency anemia expertise in heart failure, kidney disease, gastroenterology or inflammatory bowel disease, patient blood management and women’s health, we help patients affected by these conditions to live better, healthier lives.
CSL is a global specialty biotherapeutics company that develops and delivers innovative biotherapies that save lives, and help people with life-threatening medical conditions live full lives.
- Phone
- 610-878-4000
- Location
- 1020 First Avenue
King of Prussia
Pennsylvania
19406